Clinical Trial Update: Interleukin-2-Induced Cognitive/Affective/Sleep Symptoms

View source ↗

Summary

A clinical trial update notes cognitive, affective, and sleep symptoms linked to high-dose interleukin-2. The conditions involved are metastatic renal cell carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Renal Cell Carcinoma

Drugs mentioned

• Aldesleukin (Proleukin) (aldesleukin)

Snippet

Sponsor: Duke University | Conditions: Metastatic Renal Cell Carcinoma, Metastatic Melanoma | Status: COMPLETED